19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serum albumin level as a risk factor for mortality in burn patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVE:

          Hypoalbuminemia is a common clinical deficiency in burn patients and is associated with complications related to increased extravascular fluid, including edema, abnormal healing, and susceptibility to sepsis. Some prognostic scales do not include biochemical parameters, whereas others consider them together with comorbidities. The purpose of this study was to determine whether serum albumin can predict mortality in burn patients.

          METHODS:

          We studied burn patients ≥16 years of age who had complete clinical documentation, including the Abbreviated Burn Severity Index, serum albumin, globulin, and lipids. Sensitivity and specificity analyses were performed to determine the cut-off level of albumin that predicts mortality.

          RESULTS:

          In our analysis of 486 patients, we found that mortality was higher for burns caused by flame ( p = 0.000), full-thickness burns ( p = 0.004), inhalation injuries ( p = 0.000), burns affecting >30% of the body surface area ( p = 0.001), and burns associated with infection ( p = 0.008). Protein and lipid levels were lower in the patients who died ( p<0.05). Albumin levels showed the highest sensitivity and specificity (84% and 83%, respectively), and the area under the receiver-operating characteristic curve (0.869) had a cut-off of 1.95 g/dL for mortality.

          CONCLUSION:

          Patients with albumin levels <2 g/dL had a mortality risk of >80%, with 84% sensitivity and 83% specificity. At admission, the albumin level could be used as a sensitive and specific marker of burn severity and an indicator of mortality.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Human albumin administration in critically ill patients: systematic review of randomised controlled trials.

          (1998)
          To quantify effect on mortality of administering human albumin or plasma protein fraction during management of critically ill patients. Systematic review of randomised controlled trials comparing administration of albumin or plasma protein fraction with no administration or with administration of crystalloid solution in critically ill patients with hypovolaemia, burns, or hypoalbuminaemia. 30 randomised controlled trials including 1419 randomised patients. Mortality from all causes at end of follow up for each trial. For each patient category the risk of death in the albumin treated group was higher than in the comparison group. For hypovolaemia the relative risk of death after albumin administration was 1.46 (95% confidence interval 0.97 to 2.22), for burns the relative risk was 2.40 (1.11 to 5.19), and for hypoalbuminaemia it was 1.69 (1.07 to 2.67). Pooled relative risk of death with albumin administration was 1.68 (1.26 to 2.23). Pooled difference in the risk of death with albumin was 6% (95% confidence interval 3% to 9%) with a fixed effects model. These data suggest that for every 17 critically ill patients treated with albumin there is one additional death. There is no evidence that albumin administration reduces mortality in critically ill patients with hypovolaemia, burns, or hypoalbuminaemia and a strong suggestion that it may increase mortality. These data suggest that use of human albumin in critically ill patients should be urgently reviewed and that it should not be used outside the context of rigorously conducted, randomised controlled trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study.

            To improve the precision and reliability of estimates of the association between preoperative serum albumin concentration and surgical outcomes. Prospective observational study. Patients were followed up for 30 days postoperatively. Multiple logistic regression models were developed to evaluate serum albumin level as a predictor of operative mortality and morbidity in relation to 61 other preoperative patient risk variables. Forty-four tertiary care Veterans Affairs (VA) medical centers. A total of 54215 major noncardiac surgery cases from the National VA Surgical Risk Study. Thirty-day operative mortality and morbidity. A decrease in serum albumin from concentrations greater than 46 g/L to less than 21 g/L was associated with an exponential increase in mortality rates from less than 1% to 29% and in morbidity rates from 10% to 65%. In the regression models, albumin level was the strongest predictor of mortality and morbidity for surgery as a whole and within several subspecialties selected for further analysis. Albumin level was a better predictor of some types of morbidity, particularly sepsis and major infections, than other types. Serum albumin concentration is a better predictor of surgical outcomes than many other preoperative patient characteristics. It is a relatively low-cost test that should be used more frequently as a prognostic tool to detect malnutrition and risk of adverse surgical outcomes, particularly in populations in whom comorbid conditions are relatively frequent.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis.

              To assess whether resuscitation with albumin-containing solutions, compared with other fluids, is associated with lower mortality in patients with sepsis. MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases, the metaRegister of Controlled Trials, and the Medical Editors Trial Amnesty Register. Prospective randomized clinical trials of fluid resuscitation with albumin-containing solutions compared with other fluid resuscitation regimens, which included a population or subgroup of participants with sepsis, were included. Assessment of the validity of included studies and data extraction were conducted independently by two authors. For the primary analysis, the effect of albumin-containing solutions on all-cause mortality was assessed by using a fixed-effect meta-analysis. Seventeen studies that randomized 1977 participants were included in the meta-analysis. There were eight studies that included only patients with sepsis and nine where patients with sepsis were a subgroup of the study population. There was no evidence of heterogeneity, I² = 0%. The use of albumin for resuscitation of patients with sepsis was associated with a reduction in mortality with the pooled estimate of the odds ratio of 0.82 (95% confidence limits 0.67-1.0, p = .047). In this meta-analysis, the use of albumin-containing solutions for the resuscitation of patients with sepsis was associated with lower mortality compared with other fluid resuscitation regimens. Until the results of ongoing randomized controlled trials are known, clinicians should consider the use of albumin-containing solutions for the resuscitation of patients with sepsis.
                Bookmark

                Author and article information

                Journal
                Clinics (Sao Paulo)
                Clinics (Sao Paulo)
                Clinics
                Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
                1807-5932
                1980-5322
                July 2013
                : 68
                : 7
                : 940-945
                Affiliations
                [I ]Specialties Hospital of the Western Medical Center, Medical Unit of High Specialty, Mexican Institute of Social Security, Internal Medicine and Geriatrics Department, Guadalajara, Jalisco/Mexico.
                [II ]Specialties Hospital of the Western Medical Center, Medical Unit of High Specialty, Mexican Institute of Social Security, Burn Unit, Guadalajara, Jalisco/Mexico.
                [III ]Specialties Hospital of the Western Medical Center, Medical Unit of High Specialty, Mexican Institute of Social Security, Research Unit in Clinical Epidemiology, Guadalajara, Jalisco/Mexico.
                [IV ]Mexican Institute of Social Security, Coordination of Health Research, La Paz, Baja California Sur/Mexico.
                Author notes

                Aguayo-Becerra OA, Torres-Garibay C, Macías-Amezcua MD, Fuentes-Orozco C, and González-Ojeda A participated in the protocol design, statistical analysis, and editing and final critical revision of the manuscript. Chávez-Tostado MG, Andalón-Dueñas E, Espinosa-Partida A, Álvarez-Villaseñor AS, and Cortés-Flores AO were involved in identifying and recruiting burn patients and the critical revision of the final version of the manuscript.

                E-mail: avygail5@ 123456gmail.com Tel.: 52 33 3848-5410
                Article
                cln_68p940
                10.6061/clinics/2013(07)09
                3714858
                23917657
                26626aa1-2af4-4fd7-9821-4e56d3f2f6f5
                Copyright © 2013 Hospital das Clínicas da FMUSP

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 16 January 2013
                : 11 February 2013
                : 11 March 2013
                Page count
                Pages: 6
                Categories
                Clinical Science

                Medicine
                burns,level of severity of injury,serum albumin,mortality
                Medicine
                burns, level of severity of injury, serum albumin, mortality

                Comments

                Comment on this article